Investigation of Remaxol Efficacy in Complex Therapy of Experimental Generalized Tuberculosis on Mice

Investigation of Remaxol Efficacy in Complex Therapy of Experimental Generalized Tuberculosis on Mice

Efficacy of remaxol In complex chemotherapy of generalized drug resistant tuberculosis was studied on mice. Mycobacterium tuberculosis 5419 SPBNIIF isolated from a patient with freshey diagnosticated pulmonary tuberculosis resistant to isoniazid (10 mcg/ml), rifampicin (40 mcg/ml), streptomycin (10...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. S. Sukhanov, T. I. Vinogradova, A. V. Elkin, N. V. Zabolotnykh, S. N. Vasilyeva, M. L. Vitovskaya
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	experimental tuberculosis drug resistance chemotherapy remaxol
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/417
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Remaxol Hepatoprotective Therapy of Patients with Tuberculosis and HIV Infection in Day Unit of Tuberculosis Dispensary
by: E. V. Shevyreva, et al.
Published: (2020-05-01)

EFFICACY OF REMAXOL AND ADEMETHIONINE IN EXPERIMENTAL LIVER DAMAGE CAUSED BY A COMBINATION OF RESERVE-SERIES ANTITUBERCULOSIS DRUGS AND ALCOHOL
by: D. S. Sukhanov, et al.
Published: (2014-04-01)

Efficiency of Remaxol Use in Supporting Treatment of Advanced Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Application of Hepatoprotector Remaxol in the Treatment of Patients Co-Infected with Tuberculosis, HIV, and Chronic Hepatitis C
by: YU. G. Pritulina, et al.
Published: (2020-05-01)

Comparative Efficacy of Clinical Use of Reamberin, Remaxol and Ademethionine in Patients with Tuberculosis of the Respiratory Organs and Liver Drug-Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

REMAXOL: MECHANISMS OF ACTION AND APPLICATION IN REAL CLINICAL PRACTICE
by: L. Yu. Ilchenko, et al.
Published: (2016-05-01)

Remaxol in Correction of Functional Hepatic Failure in Patients with Acute Biliary Pancreatitis
by: A. P. Vlasov, et al.
Published: (2020-05-01)

Real-World Clinical and Economic Efficacy of Succinate-Based Therapy with Remaxol of Alcohol Hepatitis
by: L. Yu. Il’chenko, et al.
Published: (2024-02-01)

Some Peculiarities of Modern Comorbid Tuberculosis Therapy
by: V. M. Kolomiets, et al.
Published: (2023-02-01)

Effect of dalargin and remaxol on endocrine and metabolic disorders in patients with thoracoabdominal trauma
by: A. G. Miroshnichenko, et al.
Published: (2021-05-01)

Comorbid Tuberculosis in the Context of the Formation of a Local Epidemic Situation
by: V. M. Kolomiets, et al.
Published: (2025-02-01)

The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
by: V. M. Kolomiets, et al.
Published: (2020-12-01)

DRUG-INDUCED LIVER LESIONS AND THEIR MANAGEMENT IN THE MANIFESTATIONS OF TUBERCULOSIS
by: A. V. Mordyk, et al.
Published: (2015-09-01)

Hepatotropic Therapy in Treatment of Liver Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Metaanalytic Approach to Evaluate Clinical Effectiveness of Infusion Succinnate-Containing Remaxol in Liver Pathologies of Diverse Genesis
by: N. K. Mazina, et al.
Published: (2020-05-01)

The eﬀectiveness of psychological support with the use of hepato-immunoprotectors as predictors in drug therapy of tuberculosis
by: V. M. Kolomiets, et al.
Published: (2021-08-01)

Predictors of the Effectiveness of Psychological Support in Addition to the Base Treatment in Pulmonary Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2024-01-01)

The Problem of Comorbid Socially Significant Infections Under The Conditions of The COVID-19 Pandemic
by: V. M. KOLOMIETS, et al.
Published: (2022-11-01)

Reproductive disorders in the experimental modeling of tuberculosis
by: S. I. Kayukova, et al.
Published: (2020-03-01)

Features of complex therapy of hemorrhagic fever with renal syndrome against the background of liver damage
by: Andrey A. Shuldyakov, et al.
Published: (2024-12-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE
by: S. A. Popov, et al.
Published: (2017-02-01)

EFFICIENCY OF THE NEW MEDICATION OF FS-1 IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
by: M. E. Kulmanov, et al.
Published: (2015-12-01)

USE OF HEPATOPROTECTORS IN PATIENTS WITH OVARIAN CANCER
by: S. V. Tumanyan, et al.
Published: (2015-05-01)

Pharmacoeconomic Analysis of the Use of Hepatoprotectors in Management of Drug-Associated Liver Injury Due to Hodgkin's Lymphoma Chemotherapy
by: D. D. Morikov, et al.
Published: (2020-05-01)

RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION
by: V. V. Testov, et al.
Published: (2014-04-01)

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

Reamberin in Tuberculosis Chemotherapy and Its Effect on Liver Function
by: I. S. Gelberg, et al.
Published: (2020-05-01)

Specific features of the clinical course and chemotherapy of tuberculosis in children exposed to tuberculosis with different drug resistance patterns
by: M. E. Lozovskaya, et al.
Published: (2019-10-01)

Epidemic situation and features of accompanying therapy in the treatment of socially significant infectious diseases in penitentiary populations before, during, and after the COVID-19 pandemic
by: V. M. Kolomiets, et al.
Published: (2024-04-01)

Simulation of Conditions and Results of Implementation of Short-Course Treatment Regimes in Tuberculosis Patients
by: V. S. Burykhin, et al.
Published: (2023-12-01)

Assessment of effectiveness of the empiric treatment regimen in tuberculosis patients suspected with multiple drug resistance in the Russian Federation
by: Sergey A. Sterlikov, et al.
Published: (2018-11-01)

Pathogenetic Correction of Metabolic Disturbances in Chronic Liver Affections
by: M. G. Romantsov, et al.
Published: (2020-05-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Specific Features of the Course and Treatment of Respiratory Tuberculosis in Women during Pregnancy and Postpartum Period. Perinatal Outcomes
by: S. I. Kayukova, et al.
Published: (2023-12-01)

Bladder tuberculosis: therapy and surgery
by: Ye. V. Kulchavenya, et al.
Published: (2011-04-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)

Efficacy of standard chemotherapy regimens in children and adolescents suffering from respiratory tuberculosis
by: E. F. Luginova, et al.
Published: (2020-12-01)

Molecular-genetic substantiation of combined therapy in the early postoperative period in diffuse peritonitis
by: A. P. Vlasov, et al.
Published: (2022-05-01)